Austin, Texas – Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). CPRIT was established to expedite innovation and commercialization in the area of cancer research and […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today recommended that its stockholders take no action at this time in response to Roche’s announcement that it is now offering to acquire Illumina for $51.00 per share […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has increased its offer price for all outstanding publicly-held shares of Illumina, Inc. (NASDAQ: ILMN) to US$ 51.00 per share in cash. All other terms and conditions of the tender offer remain unchanged. Severin Schwan, Chief Executive Officer of Roche, said: “Based on our discussions […]
WOBURN, Mass — Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced the introduction of their first genetic tests using next generation sequencing (NGS) technology, propriety bioinformatics platform and highly annotated, analytic capabilities to diagnose mitochondrial disease in […]
Leuven – p. Cartagenia, the global leader in supplying diagnostic knowledge, analytic software and database systems to genetic labs and clinicians, today announced the commercial release of its BENCH lab NGS solution for clinical NGS data analysis. p. The new product is tailored to support the adoption of Next Generation Sequencing technology in routine clinical […]
LEXINGTON, Mass. AND CHARLOTTE, N.C.,– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that Greenwood Genetic Center has commercially launched its Syndromic Autism 62-Gene Panel which was built for use on RainDance’s picodroplet-based targeted sequencing platform. The panel sequences 62 individual autosomal and X-linked genes that represent the most common single gene etiologies associated […]
Today Bioo Scientific announced the launch of the NEXTflex™ Methyl-Seq 1 Kit which facilitates a methylome-level assessment of genomic DNA while allowing for the multiplexing of up to 96 samples. The NEXTflex™ Methyl-Seq 1 Kit is designed to enrich and prepare single, paired-end and multiplexed methylated DNA libraries for sequencing using Illumina® MiSeq, GAIIx and […]
Appistry, Inc., the world’s best company at solving complex, data intensive problems, today announced that the Ayrris/BIO genomic cloud service and on-premise appliance meet all HIPAA compliant standards. With this milestone, Appistry provides customers deploying Ayrris/BIO for the advanced analysis of Next Generation Sequencing data with assurance that their genomic information is private, portable and […]
CARLSBAD, Calif — Life Technologies Corporation (NASDAQ: LIFE) today launched Ion AmpliSeq™ Custom Panels that will transform disease research by unlocking hundreds of thousands of precious archived research samples containing low amounts of DNA from repositories around the globe. The highest multiplexed PCR-based solution on the market with a one-day workflow, Ion AmpliSeq™ Custom Panels […]
The agreement enables close collaboration between a research centre whose principal mission is the study of the genome and how it translates into characteristics that distinguish each individual, and an industry leader whose technology and products accelerate genetic analysis research and applications, paving the way for molecular medicine and ultimately transforming healthcare. “This is the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
